Diabetes is all over the world
The incidence rate of diabetes is rising in almost every country in the world. The number of people who die from it every year is about the same as the number of deaths caused by HIV / AIDS.
According to the statistics of the past 30 years, the prevalence of diabetes in China increased from 1% in 1980 to 5.5% in 2001 and 10.9% in 2013. In 2013, the prevalence of pre diabetes increased from 15.5% in 2008 to 35.7%. Among them, male, overweight, urban residents and the elderly, the prevalence rate is higher.
World Diabetes Day
As the 14th UN diabetes day on November 14, this year, the publicity theme was set as “nurses and diabetes”. Objective to strengthen the important role of nursing workers in diabetes health management, effectively intervene the risk factors of diabetes, promote the early detection and intervention of high-risk groups and patients, improve the self-management ability of diabetic patients, and timely correct bad living habits, such as smoking cessation, alcohol restriction, oil control, salt reduction, etc.
But what is diabetes? Many people don’t understand. Today, let’s give you a little science popularization~
Shengnuo biotechnologysmall class
Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is due to insulin secretion defect or its biological function damage, or both. The long-term existence of hyperglycemia leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves. It often appears with hypertension and hyperlipidemia, which is commonly known as “three high”.
So the question is: do peptides work for diabetes?
With the continuous in-depth research of researchers around the world, it is found that small molecular active peptide is different from the mechanism of drug action, it can directly act on beta cells, stimulate cell proliferation, induce cell regeneration, prevent islet cell apoptosis, and thus dynamically regulate the number of beta cells; when blood glucose level is low, small molecular active peptide will not induce insulin secretion to ensure its function and will not increase blood pressure The risk of sugar occurrence.
In summary, small molecular active peptides can play the following functions for diabetes mellitus:
1. To activate and repair islet cells;
2. Insulin synthesis was promoted by islet cells;
3. Two way regulation, blood glucose can be reduced when high, increased when low. It has no effect on normal blood glucose;
4. It can improve the body’s antioxidant capacity, reduce the production of oxidation products, protect the liver and kidney, reduce the degree of injury, and reduce the incidence of diabetic complications;
5. Improve human immunity, prevent and reduce its complications.
Summary
As early as 2002, peptide was listed as a national key product for development in China. As a biomedical enterprise researching peptide drugs, octreotide acetate injection developed by us can effectively control blood glucose concentration and maintain normal blood glucose. Xiaobian also warm tips here, diabetes patients should pay attention to scientific diet, reasonable exercise, exercise, quit smoking and drinking and other bad habits, maintain a good attitude, more conducive to the relief of pain.